NCT04846998 - A Study to Compare the Pharmacokinetics of BR9003A and BR9003 in Healthy Adult Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 25, 2021

Primary Completion Date

May 4, 2021

Study Completion Date

May 18, 2021

Conditions

Smoking Cessation

Interventions

DRUG

BR9003

"Treatment group B:~Once-daily oral administration of one BR9003 2mg tablet in the fasting state.~Treatment group C:~Once-daily oral administration of one BR9003 2mg tablet after a meal(high-fat meal) 30 minutes before the scheduled time of administration and finishing it."

DRUG

BR9003A

"Treatment group A:~Twice-daily oral administration of one BR9003A 1mg tablet in the fasting state"

Trial Locations (1)

Unknown

Inha University Hospital, Incheon